Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00176579 · ClinicalTrials.gov registry record
Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer
A clinical trial of Prostate Cancer and Osteoporosis, sponsored by University of Medicine and Dentistry of New Jersey.
- Completed
- Registry status
- 27
- Enrollment target
- 1
- Study location
NCT00176579 is a study of Prostate Cancer and Osteoporosis that has completed, run by University of Medicine and Dentistry of New Jersey. The registered enrollment target is 27 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00176579, a study of Prostate Cancer and Osteoporosis, has completed, sponsored by University of Medicine and Dentistry of New Jersey.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
RATIONALE: Measuring bone mineral density may help doctors predict whether prostate cancer will come back. It may also help the study of prostate cancer in the future. PURPOSE: This clinical trial is studying whether bone mineral density affects cancer recurrence in patients with early stage prostate cancer.
Conditions Studied
Interventions
- PROCEDURE dual x-ray absorptiometry
Study Locations (1)
New Jersey
- Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School - New Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2003-06 |
| Est. Completion | 2008-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00176579
The ClinicalTrials.gov registry entry for NCT00176579 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (96% lower). The listed sponsor is University of Medicine and Dentistry of New Jersey, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which dual x-ray absorptiometry is the first listed.
NCT00176579 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT00176579 about?
NCT00176579 is a clinical study titled "Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer". RATIONALE: Measuring bone mineral density may help doctors predict whether prostate cancer will come back. It may also help the study of prostate cancer in the future. PURPOSE: This clinical trial is studying whether bone mineral density affects cancer recurrence in patients with early stage prosta...
What is the current status of trial NCT00176579?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2003-06. Estimated completion is 2008-07.
What conditions does trial NCT00176579 study?
This clinical trial studies the following conditions: Prostate Cancer, Osteoporosis.
What interventions are being tested in trial NCT00176579?
The interventions under investigation include: dual x-ray absorptiometry (PROCEDURE).
Who is sponsoring clinical trial NCT00176579?
This trial is sponsored by University of Medicine and Dentistry of New Jersey, which has 88 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00176579 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
RECRUITING
-
Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer
RECRUITING · Phase 2
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.